Active Low-Carber Forums
Atkins diet and low carb discussion provided free for information only, not as medical advice.
Home Plans Tips Recipes Tools Stories Studies Products
Active Low-Carber Forums
A sugar-free zone


Welcome to the Active Low-Carber Forums.
Support for Atkins diet, Protein Power, Neanderthin (Paleo Diet), CAD/CALP, Dr. Bernstein Diabetes Solution and any other healthy low-carb diet or plan, all are welcome in our lowcarb community. Forget starvation and fad diets -- join the healthy eating crowd! You may register by clicking here, it's free!

Go Back   Active Low-Carber Forums > Main Low-Carb Diets Forums & Support > Low-Carb Studies & Research / Media Watch > LC Research/Media
User Name
Password
FAQ Members Calendar Search Gallery My P.L.A.N. Survey


Reply
 
Thread Tools Display Modes
  #1   ^
Old Mon, Sep-21-15, 14:30
RawNut's Avatar
RawNut RawNut is offline
Lipivore
Posts: 1,208
 
Plan: Very Low Carb Paleo
Stats: 270/185/180 Male 72 inches
BF:
Progress: 94%
Location: Florida
Default Oral administration of a Ketone Ester regulates blood cholesterol in rats and humans

Quote:
Control of cholesterol in Type 2 Diabetics and Pre-diabetics has been problematic as statins increase blood glucose. We propose that a unique β-hydroxybutyrate (βHB) Ester can provide non-lipogenic calories and decrease cholesterol synthesis without increasing glucose. The ketone bodies, βHB and Acetoacetate, can be metabolized by most tissues, but not liver, limiting cholesterol precursors. In humans, a single meal containing this ketone ester (KE) dose dependently decreased plasma mevalonate, a marker for cholesterol synthesis, without directly inhibiting HMG-CoA Reductase. After two days of KE, rats had 31% lower plasma cholesterol and 26% lower mevalonate than controls. In a 30 day study, KE fed rats had lower plasma total cholesterol (-40%) and mevalonate (-27%) than controls. Levels of mevalonate precursors, Acetoacetyl-CoA and HMG-CoA were lower by 33% and 54% respectively, but Acetyl-CoA was unaffected. Low liver cholesterol increases absorption of cholesterol through the Low Density Lipoprotein receptor (LDL-R), KE feeding increased LDL-R levels in whole cell (+24%) and membrane preparations (+67%). KE fed animals had increased protein levels of SREBP-2, a key transcriptional activator of LDL-R, both full length and transcriptionally active forms increased, by 91% and 140%. A 5 day study of KE effect on cholesterol in human Type 2 Diabetics showed not only lower total cholesterol (-10%) but also lower fasting glucose (-17%) and Triglycerides (-18%). We report preliminary findings that KE decreases cholesterol and its synthetic precursors while decreasing fasting blood glucose and triglycerides


http://www.fasebj.org/content/29/1_...nt/715.17.short
Reply With Quote
Sponsored Links
  #2   ^
Old Mon, Sep-21-15, 21:42
Nicekitty's Avatar
Nicekitty Nicekitty is offline
Senior Member
Posts: 469
 
Plan: Banting
Stats: 150/132/132 Female 5'7"
BF:
Progress: 100%
Location: PNW
Default

Very interesting, but I cannot seem to figure out what ketone esters are and how they relate to metabolism. Is it possible to get ketone esters from any food products? Or are they a by-product of any digestive process? This one sounds like it was manufactured for the purpose.

Basically, what I want to know is--If I'm a butter snacker, is it rotoring out my veins or do I need to add some coconut oil?
Reply With Quote
  #3   ^
Old Tue, Sep-22-15, 07:24
teaser's Avatar
teaser teaser is offline
Senior Member
Posts: 15,075
 
Plan: mostly milkfat
Stats: 190/152.4/154 Male 67inches
BF:
Progress: 104%
Location: Ontario
Default

Neither. Once it's a ketone, the liver won't metabolize it. With coconut oil or butter--the ketones won't be produced unless the liver metabolizes the fat--leaving the potential for cholesterol production, etc., in the process of breaking down the fat while producing the ketones. Of course that depends on whether their explanation for the decrease is correct--that it's caused by decreased substrate availability in the liver--rather than there being some sort of signalling cascade that reduces cholesterol production in the liver, responsive to ketones.

There might be trace amounts of ketone in food, but nothing like supplementation.

One potentially nice thing here is that while the ketones might be decreasing cholesterol production in the liver itself, they have the potential to provide substrate for cholesterol production in other parts of the body, like the brain.

It will be interesting to see, when the group later releases a longer paper, what happened to people's insulin levels in the study.
Reply With Quote
  #4   ^
Old Tue, Sep-22-15, 10:30
Nicekitty's Avatar
Nicekitty Nicekitty is offline
Senior Member
Posts: 469
 
Plan: Banting
Stats: 150/132/132 Female 5'7"
BF:
Progress: 100%
Location: PNW
Default

I understand the concept of ketones, I'm just trying to figure out what a ketone ester is and how it fits into the equation. Apparently it is an artificially produced chemical that is rapidly broken down into ketones? The whole point being to get the benis without actually eating a ketogenic diet it seems. This article provided a bit of insight:

http://high-fat-nutrition.blogspot....-dangerous.html

So are they investigating the use of these ketone esters as a possible supplement (to SAD?) or the possible benefits of a ketogenic diet? Seems like the former.
Reply With Quote
  #5   ^
Old Tue, Sep-22-15, 11:02
teaser's Avatar
teaser teaser is offline
Senior Member
Posts: 15,075
 
Plan: mostly milkfat
Stats: 190/152.4/154 Male 67inches
BF:
Progress: 104%
Location: Ontario
Default

I think though, in the same way that early studies showing an advantage to lowering cholesterol through drugs lead people to jump to the conclusion that lowering cholesterol through diet was a good idea--if supplemental ketones catch on as a treatment, that might give dietary ways of entering ketosis a boost in popularity--whether for the right reason or not. Even if part of the purpose of the studies is to find a way to put people in ketosis without risking a high fat diet.

In the case of type II diabetics--it might just take a bit more to get into ketosis. Or take somebody like Jimmy Moore, he just did a 17 day fast, while his wife was doing a low-carb autoimmune diet--and her ketones and blood glucose were around the same level as his.

Some of the therapeutic ketogenic diets are very aggressive. If a person needs to eat 90 percent of calories as fat--and even then, still has to watch their calories, to get the level of ketosis/suppression of glucose metabolism desired--there's a case where being able to eat a bit less stringent diet would be nice, and maybe compliance more likely. In the extreme, a person might be forced to choose between optimizing for ketosis, and getting in enough protein to sustain lean mass.

And I guess if somebody can eat a high carb diet, and still get some benefits from exogenous ketones, that's something worth knowing. There will always be people willing to take the supplement, but not willing to change their diet. I know people who think a low carb diet would improve their cholesterol--but they take statins, they think it's "instead," that it will protect them from their diet choice. It'd be nice if ketone esters actually provided some of the protection they hope for from statins.
Reply With Quote
  #6   ^
Old Tue, Sep-22-15, 11:12
teaser's Avatar
teaser teaser is offline
Senior Member
Posts: 15,075
 
Plan: mostly milkfat
Stats: 190/152.4/154 Male 67inches
BF:
Progress: 104%
Location: Ontario
Default

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821009/

This is a paper on ketone esters by Veech, and yeah, there is some prejudice against a ketogenic diet there;

Quote:
There are important differences between feeding ketone esters (as in the study described earlier) and feeding a ketogenic diet. Ketogenic diets have been fed to humans since they were proposed by Russell Wilder at the Mayo Clinic in 19219 following the finding by Hugh Conkin10 that fasting resulted in a cessation of seizures in a child with intractable epilepsy. Since that time, the ketogenic diet has been used to treat drug-resistant epilepsy.11 Because of their rapid absorption, blood ketone levels of any desired level can be achieved by feeding the ketone ester, whereas feeding a ketogenic diet may produce diverse levels of ketone bodies depending upon the amount of carbohydrate or protein of the diet. A high-fat diet can lead to significant elevation of blood ketones, but also to an elevation of blood free fatty acids which in humans leads to a deterioration in both physical and cognitive performance.12 In addition, feeding a ketogenic diet can lead to an elevation of blood cholesterol and triglycerides which is undesirable in anyone over 17 years of age because of it atherogenic potential.13


It would be interesting to see, in people who do get elevated cholesterol and triglycerides on a ketogenic diet (I think the second is rarer than the first), what happens with ketone esters being added in.
Reply With Quote
  #7   ^
Old Tue, Sep-22-15, 18:38
M Levac M Levac is offline
Senior Member
Posts: 6,498
 
Plan: VLC, mostly meat
Stats: 202/200/165 Male 5' 7"
BF:
Progress: 5%
Location: Montreal, Quebec, Canada
Default

So, if we eat ketones, and the liver responds, then the liver has the ability to see ketones coming in. Did they measure insulin?
Quote:
We report preliminary findings that KE decreases cholesterol and its synthetic precursors while decreasing fasting blood glucose and triglycerides

Injecting ketones drops BG and insulin. Eating ketones should have the same effect. It has the same effect on BG in this experiment. Insulin regulates triglycerides metabolism, so it should have the same effect on insulin too.
Quote:
The ketone bodies, βHB and Acetoacetate, can be metabolized by most tissues, but not liver, limiting cholesterol precursors.

If I'm not mistaken, ketones can't be metabolized into cholesterol. So their idea of substrate-driven regulation is obviously wrong. So it must be all about signaling. So the liver must have the ability to see ketones coming in.
Reply With Quote
  #8   ^
Old Tue, Sep-22-15, 20:57
teaser's Avatar
teaser teaser is offline
Senior Member
Posts: 15,075
 
Plan: mostly milkfat
Stats: 190/152.4/154 Male 67inches
BF:
Progress: 104%
Location: Ontario
Default

https://en.wikipedia.org/wiki/Meval...hi_def_tiff.tif

https://en.wikipedia.org/wiki/Ketog...Ketogenesis.svg

Check out the ketogenesis and mevalonate pathways. Up to the point of HMG CoA, it's identical. At that point, HMG CoA lyase can produce an acetoacetate and an Acetyl-CoA, or HMG reductase produces mevalonate.

I first found the Hyperlipid blog when Peter commented on a Dr. Davis post about using niacin to reduce ldl and triglycerides, and raise hdl. Peter was commenting that beta-hydroxybutyrate was also a ligand for certain nicotinic acid receptors (and maybe they should have been named ketone receptors in the first place, for all we know).

Quote:
Nicotinic acid receptor subtypes and their ligands.
Soudijn W1, van Wijngaarden I, Ijzerman AP.
Author information
Abstract
Half a century ago, nicotinic acid (niacin) was introduced into the clinic as the first orally available drug to treat high cholesterol levels and to improve the balance between (V)low density lipoproteins (LDL) and high density lipoproteins (HDL). Remarkably, its putative mechanism of action has only been recently elucidated, particularly because of the cloning of a G protein-coupled receptor (HM74A or GPR109A). This receptor responds to both nicotinic acid and the ketone body beta-hydroxybutyrate, the latter thought to be the more probable endogenous ligand for HM74A. In this review, we will discuss the pharmacology and medicinal chemistry of this receptor subtype and a related one (HM74 or GPR109B). Although still in its infancy, the ligand repertoire is developing, and a number of compound classes have now been described, among which are both full and partial agonists. Antagonists, however, are still lacking, thus compromising thorough pharmacological studies. Mutagenesis experiments have provided clues regarding the ligand binding site; in particular, an arginine residue in transmembrane domain 3 of the receptor seems to recognize the acidic moiety present in nicotinic acid and related substances. HM74A has also been linked to one of the major side effects of nicotinic acid, that is, flushing, since this receptor subtype also occurs in skin immune cells. It is not known yet whether HM74 is also present on these cells. Since nicotinic acid is one of the few available medicines that raise HDL ("good cholesterol") levels, HM74A and HM74 appear promising targets for future pharmacotherapy.


One thing nicotinic acid signalling does is reduce lipolysis, and this makes sense when ketones are high, usually--since, if they weren't already at an adequate level, then where did all those ketones come from?

That GPR109A receptor is found in the liver (at least in mouse livers), at much lower levels than in adipocytes. So there's at least one way for the liver to directly sense the ketones. But reduced lipolysis, leading to reduced beta oxidation and reduction in the Acetyl-CoA needed for cholesterol production in the liver also makes sense.

Okay, here's some full text, more detail on reduction of lipolysis through this receptor;

http://www.jbc.org/content/280/29/26649.full

Quote:
(D)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G*


Lowered triglycerides could be secondary to a reduction in lipolysis. Not necessarily as bad as it sounds, this might make for a more rapid depletion of glycogen stores between meals and especially during the longer fast of sleep. That might reduce blood glucose and insulin, but I might be stringing together too many mights here.
Reply With Quote
  #9   ^
Old Tue, Sep-22-15, 23:24
M Levac M Levac is offline
Senior Member
Posts: 6,498
 
Plan: VLC, mostly meat
Stats: 202/200/165 Male 5' 7"
BF:
Progress: 5%
Location: Montreal, Quebec, Canada
Default

If both nicotinic acid and ketones act on the same receptor, and if nicotinic acid has the ability to inhibit lipolysis, then ketones also have this ability, which gives credence to my paradigm, which says blood ketones level regulates ketogenesis in the liver through a negative feedback loop, i.e. more ketones, less ketogenesis, and vice versa.

Since eating ketones drops BG in this experiment, it must also act on glycogen/glycogenolysis in the liver as well. There must be a pathway. If insulin is involved anywhere in that pathway, it opens the door to insulin degradation, we get lower insulin.

Glucose likely has the ability to inhibit ketogenesis too, likely by using insulin too. But then, it could also have the ability to inhibit insulin degradation, we get the typical profile of low ketones high BG and high insulin. As glucose drops, there's less inhibition of insulin degradation, insulin drops, ketogenesis picks up, negative feedback loop, all things are now regulated. Inject/eat ketones, ketones force the feedback loop.

As for cholesterol, if insulin is involved anywhere in that pathway, and since excess glucose raises insulin, it follows that merely eating carbs will disrupt cholesterol metabolism.
Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT -6. The time now is 08:28.


Copyright © 2000-2024 Active Low-Carber Forums @ forum.lowcarber.org
Powered by: vBulletin, Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.